AI-generated summary
The authors review current strategies to limit secondary cochlear damage after cochlear implantation and assess photobiomodulation as a possible adjuvant therapy. They report that photobiomodulation may protect auditory cells and could improve electric-acoustic stimulation device performance in people with residual hearing, and that postoperative implantation is accompanied by inflammatory cytokine upregulation. The authors conclude that the neuroprotective potential of photobiomodulation needs further validation.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract does not report a specific sample, study design, or wavelength, and its neuroprotective conclusions are stated as requiring further validation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.